Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report

A 59-year-old Japanese woman was admitted for evaluation of muscle weakness. Autosomal dominant polycystic kidney disease had been diagnosed at the age of 47 years, followed by primary aldosteronism at 53 years. At the age of 58, tolvaptan was started (60 mg/day) to treat her renal disease. After 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunizawa, Kyohei, Hoshino, Junichi, Mizuno, Hiroki, Suwabe, Tatsuya, Sumida, Keiichi, Kawada, Masahiro, Yamanouchi, Masayuki, Sekine, Akinari, Hayami, Noriko, Hiramatsu, Rikako, Hasegawa, Eiko, Sawa, Naoki, Takaichi, Kenmei, Shibata, Shigeru, Ubara, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903093/
https://www.ncbi.nlm.nih.gov/pubmed/29692992
http://dx.doi.org/10.1159/000487921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903093/
https://www.ncbi.nlm.nih.gov/pubmed/29692992
http://dx.doi.org/10.1159/000487921

Ejemplares similares